Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Completed · Phase 3 · Has a placebo group

Conditions studied: Chronic Low Back Pain

In brief

The primary purpose of the study is to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).

Key facts

Study ID

NCT00763321

Run by

AbbVie (prior sponsor, Abbott)

People needed

287

Starts

2008-09-01

Expected to finish

2009-04-01

Last updated by the study team

2014-02-06

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult male and female subjects who voluntarily sign the informed consent
• Diagnosis of CLBP of 6 months duration

You may not qualify if…

• Incapacitated or bedridden subjects
• Subjects with history of surgical or invasive intervention

Where it is running

• Site Reference ID/Investigator# 10044 — Huntsville, Alabama, United States
• Site Reference ID/Investigator# 10070 — Burbank, California, United States
• Site Reference ID/Investigator# 10050 — San Diego, California, United States
• Site Reference ID/Investigator# 10060 — Atlantis, Florida, United States
• Site Reference ID/Investigator# 10069 — Hollywood, Florida, United States
• Site Reference ID/Investigator# 10045 — Kissimmee, Florida, United States
• Site Reference ID/Investigator# 10061 — Tampa, Florida, United States
• Site Reference ID/Investigator# 10054 — Atlanta, Georgia, United States
• Site Reference ID/Investigator# 10071 — Marietta, Georgia, United States
• Site Reference ID/Investigator# 13604 — Chicago, Illinois, United States
• Site Reference ID/Investigator# 10053 — Evansville, Indiana, United States
• Site Reference ID/Investigator# 10055 — Newburgh, Indiana, United States
• Site Reference ID/Investigator# 10043 — Valparaiso, Indiana, United States
• Site Reference ID/Investigator# 10072 — Prairie Village, Kansas, United States
• Site Reference ID/Investigator# 10041 — Pasadena, Maryland, United States
• Site Reference ID/Investigator# 10049 — Springfield, Massachusetts, United States
• Site Reference ID/Investigator# 10062 — Biloxi, Mississippi, United States
• Site Reference ID/Investigator# 10066 — Florissant, Missouri, United States
• Site Reference ID/Investigator# 10073 — St Louis, Missouri, United States
• Site Reference ID/Investigator# 10056 — Omaha, Nebraska, United States
• Site Reference ID/Investigator# 10075 — Williamsville, New York, United States
• Site Reference ID/Investigator# 10065 — Winston-Salem, North Carolina, United States
• Site Reference ID/Investigator# 10067 — Fargo, North Dakota, United States
• Site Reference ID/Investigator# 10047 — Oklahoma City, Oklahoma, United States
• Site Reference ID/Investigator# 10052 — Altoona, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.